What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
August, 4 2023
Lung cancer is known for its aggressiveness. In recent years, new hopes have arisen for patients with the advent of […]
News
July, 5 2023
On June 30th and July 1st, this year’s I3LUNG Annual Meeting took place at the MEDSIR offices in Barcelona, Spain. […]
News
May, 31 2023
The Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy (I3LUNG) consortium, funded by Horizon Europe, is […]